Standigm
AI-based drug discovery, saving time and cost when compared to traditional methods.
Launch date
Employees
Market cap
-
Enterprise valuation
€42—63m (Dealroom.co estimates Mar 2019.)
Company register number 6378600053
Seoul South Korea (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $280k | Seed | |
$440k | Seed | ||
$250k | Seed | ||
$3.0m | Series A | ||
$11.5m | Series B | ||
| N/A | $8.6m | Series B | |
$44.5m | Growth Equity VC | ||
$10.0m | Growth Equity VC | ||
| Total Funding | €71.4m | ||
Related Content
Recent News about Standigm
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.